Mylan (MYL) has made an upside breakout from a nine-month base pattern.
More from Investing
You can't rush drugs to market and you can't rush a market bottom.
Traders could probe the long side of CRM at current levels.
What you are looking for right now are stocks that haven't moved that can get the credit they need.
A few favorable signals are starting to emerge on the charts of the private-label maker of pharmaceutical and wellness products.